A Yale-led research team tested 889 wild and domestic mammals across 27 species in the Northeastern United States and found zero traces of SARS-CoV-2 in any of them. The finding, published in Scientific Reports in early 2026 with senior author Caroline Zeiss, stands in sharp contrast to the widespread animal infections documented just a few years earlier, when white-tailed deer across the country tested positive at alarming rates. The results point to a specific biological mechanism: as the virus adapted to spread more efficiently among humans, it lost its grip on animal hosts.
The new data also reshape one of the most unsettling questions from the early pandemic years: whether wildlife might harbor long-term reservoirs capable of re-seeding outbreaks in people. For now, at least in the region studied, the absence of detectable virus suggests that the evolutionary path SARS-CoV-2 took in humans has made it increasingly ill-suited to persist in many nonhuman mammals. That conclusion does not erase earlier risks or guarantee future safety, but it does narrow the plausible routes by which dangerous new variants might emerge from animal populations.
When Wildlife Carried the Virus
Between 2020 and 2022, the prospect of SARS-CoV-2 establishing permanent reservoirs in wild animals ranked among the top concerns for virologists and public health officials. White-tailed deer became the most prominent case. A nationwide sampling effort by the USDA’s Animal and Plant Health Inspection Service covered over 11,000 deer and found that 12.2% were PCR-positive for the virus while 31.6% showed antibody evidence of prior exposure. Those numbers confirmed that human-to-deer spillovers had occurred repeatedly and that the virus was circulating among deer populations on its own.
Genomic analysis reinforced the alarm. Researchers documented sustained transmission in free-ranging white-tailed deer and identified viral lineages that had diverged from the strains circulating in humans at the same time. That divergence raised a pointed worry: if the virus evolved independently inside animal populations, it could eventually produce a variant better equipped to reinfect people or evade existing immunity. The fear was not abstract. Parallel evolution in a large, geographically dispersed host species like white-tailed deer represented a plausible route for a dangerous new strain to emerge.
The Connecticut Study That Found Nothing
Against that backdrop, the Yale-led surveillance effort set out to determine whether SARS-CoV-2 was still present in wildlife in the Northeastern United States, centered in Connecticut. The team sampled 889 animals from 27 species, including both wild and domestic mammals. Using RT-PCR testing and metagenomic sequencing, two of the most sensitive detection methods available, they found no SARS-CoV-2 in any animal. The result was not a matter of looking in the wrong places or testing too few specimens. The sample size was substantial, the geography overlapped with areas where infections had previously been documented, and the methods were designed to catch even low-level viral presence.
The study also included controlled infection experiments with white-footed mice, a species widely suspected of serving as a reservoir. Those experiments confirmed that white-footed mice remain biologically susceptible to SARS-CoV-2 in laboratory settings. Yet in the field, the virus was simply absent. Earlier fieldwork in the same region had already hinted at this pattern. A separate survey of white-footed mice in Connecticut found low neutralizing-antibody seroprevalence and no active virus by RT-qPCR, though it did detect divergent non-SARS betacoronaviruses in the mice. The animals were hosting other coronaviruses but not the pandemic strain.
How the Virus Evolved Away From Animals
The explanation centers on changes in the spike protein, the molecular key SARS-CoV-2 uses to enter cells. As the virus cycled through billions of human infections and produced successive variants, natural selection favored mutations that improved binding to human ACE2 receptors. That optimization came at a cost. Research published in Virus Evolution found that SARS-CoV-2 spike variants showed progressive loss of affinity to ACE2 receptors in multiple animal species. In practical terms, the virus became better at infecting people and worse at infecting deer, mice, and other mammals.
The Omicron variant, which became dominant in human populations starting in late 2021, appears to have accelerated this shift. According to Yale News coverage of the Connecticut work, Omicron sheds less virus and does not transmit between mice in experimental settings, even when the animals are housed together. That behavioral change in the virus itself, not any intervention targeting wildlife, appears to be the primary driver behind the disappearance of animal infections. The virus did not stop circulating in animals because of quarantine measures or habitat changes; it stopped because it no longer fit the biological lock on animal cells as well as it once did.
Deer Surveillance Shows a More Complex Picture
The Connecticut findings do not mean the animal reservoir problem has been fully resolved everywhere. A large-scale cervid surveillance effort conducted between October 2021 and October 2023 documented changes over time in viral and antibody prevalence among deer and found that variants circulating in cervids differed from those in humans during the same period. That divergence suggests deer populations may have sustained their own transmission chains for a time, even as the virus was fading from other wildlife species. The picture is not one of uniform disappearance but rather of a virus losing its foothold unevenly across different host species and regions.
Public health agencies have responded by emphasizing vigilance without alarm. The CDC notes that various susceptible wildlife species can be infected and that free-ranging animals in the United States have tested positive in previous surveillance. At the same time, the agency assesses the overall risk of people contracting COVID-19 from animals as low, especially compared with the dominant human-to-human transmission route. That stance mirrors the emerging scientific consensus: animal infections matter most as a potential source of new variants, not as a major direct pathway of infection for the general public.
What the Absence of Virus Means for Future Surveillance
The apparent decline of SARS-CoV-2 in Northeastern wildlife offers a cautious success story for evolutionary dynamics working in humanity’s favor. As the virus honed its ability to spread among people, it inadvertently narrowed its ecological niche, reducing its capacity to persist in many nonhuman hosts. Yet that outcome does not remove the need for ongoing monitoring. Coronaviruses as a family are notorious for their ability to jump species, recombine, and adapt. The broader literature indexed in databases such as the National Center for Biotechnology Information underscores how frequently animal coronaviruses emerge, circulate silently, and occasionally spill over into humans.
For researchers and policymakers, the Connecticut study provides both reassurance and a blueprint. It shows that targeted, high-sensitivity surveillance can confirm when an anticipated animal reservoir fails to materialize, allowing resources to be redirected to more pressing threats. At the same time, the work highlights the value of pairing field sampling with experimental infection studies to understand not just where the virus is, but where it could go next. As SARS-CoV-2 continues to evolve in humans, and as other coronaviruses circulate in wildlife, maintaining flexible surveillance systems will be key to spotting, and ideally interrupting, the next potential spillover before it becomes a global crisis.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
